hotspot -WSS

hotspot

author：explore 2025-08-12 11:30:07 - browse：3138

insulin biosimilar — The suit, filed in a Texas federal court by the American Clinical Laboratory Association and PCR lab HealthTrackRx, claims the FDA does not have the authority to scrutinize lab-developed tests. Jacquelyn Martin/AP

A group representing clinical labs across the country sued the Food and Drug Administration on Wednesday over the agency’s plan to actively regulate lab-developed tests.

The suit, filed in a Texas federal court by the American Clinical Laboratory Association and PCR lab HealthTrackRx, claims the FDA does not have the authority to scrutinize lab-developed tests. When the FDA finalized its test regulation plan last month, several experts said it was only a matter of time until someone in the lab industry sued.

Tests made in labs have historically gone unregulated by the FDA, as the agency considered them low-risk when it started regulating medical devices in 1976. But the tests have since become more numerous and complex, and the regulatory gray area enabled unreliable tests to thrive and harm patients. Infamous examples include Theranos’ blood tests, as well as misleading prenatal genetic tests from a range of companies.

STAT+ Exclusive Story

Already have an account? Log in

This article is exclusive to STAT+ subscribers

Unlock this article — plus daily intelligence on Capitol Hill and the life sciences industry — by subscribing to STAT+.

Already have an account? Log in

Monthly

$39

Totals $468 per year

$39/month Get Started

Totals $468 per year

Starter

$30

for 3 months, then $39/month

$30 for 3 months Get Started

Then $39/month

Annual

$399

Save 15%

$399/year Get Started

Save 15%

11+ Users

Custom

Savings start at 25%!

Request A Quote Request A Quote

Savings start at 25%!

2-10 Users

$300

Annually per user

$300/year Get Started

$300 Annually per user

View All Plans

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Supreme Court strikes down use of affirmative action
Next article： Let's speed up science by embracing open access publishing

WSS

ASCO: Palliative care found as helpful given virtually as in person

Accuser says Kevin Spacey grope wasn't a caress: ‘It was like a cobra ... angry’

ASCO 2024: 'Reassuring' Corbus data on ADC bladder cancer drug

Following judge's order, DOJ releases slightly less

A bus careens into a gulch in southern Mexico, leaving 27 people dead

A bus careens into a gulch in southern Mexico, leaving 27 people dead

focus

hotspot

This article is exclusive to STAT+ subscribers

Unlock this article — plus daily intelligence on Capitol Hill and the life sciences industry — by subscribing to STAT+.

hotspot

ChatGPT in medicine: STAT answers readers' burning questions

ASCO: AstraZeneca's hat trick, and palliative care's spotlight

Medicare details structure of new drug price negotiation program

Search warrant issued in 1996 disappearance of Kristin Smart

Food as medicine: CMS rules hamper 'prescribing' of fruits, veggies

A bus careens into a gulch in southern Mexico, leaving 27 people dead

Biden outlines 'new path' to provide student loan relief after Supreme Court rejection

2 million sign

Food as medicine: CMS rules hamper 'prescribing' of fruits, veggies

Search warrant issued in 1996 disappearance of Kristin Smart

entertainment

Pentagon will tighten controls on classified information after Discord leak

Former New York Mayor de Blasio and wife announce separation, but not divorce

How to increase colonoscopy rates? Looks like an AI can help

Gov. Ron DeSantis' push for 'civics' education: What does it look like?

Israel withdraws forces after 2

The leaders of Italy and Poland say European Union should focus on stopping migration

focus

leisure time

knowledge

hotspot